Stoke Therapeutics, Inc.

STOK

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001623526

SEC filings (opens in a new tab)

In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Stoke Therapeutics, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of STOK: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	130	1	126	−3
Shares	58.1M	108.1K	63.4M	+5.43M (+9.4%)
Value	$640.4M	$1.19M	$421.6M	−$217.7M (−34.1%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Stoke Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to STOK in Q1 2025
Institution	Shares	Value	% of portfolio
Erste Asset Management GmbH	396,000	$2.67M	0.03%
Jacobs Levy Equity Management, Inc	357,248	$2.38M	0.01%
Nuveen, LLC	108,087	$718.8K	0.00%
Kennondale Capital Management LLC	42,100	$280.0K	0.31%
XTX Topco Ltd	40,181	$267.2K	0.01%
ADAR1 Capital Management, LLC	30,085	$200.1K	0.04%
Dauntless Investment Group, LLC	28,600	$190.2K	0.70%
Aquatic Capital Management LLC	23,643	$157.2K	0.00%
Net Worth Advisory Group	20,741	$137.7K	0.04%
Russell Investments Group, Ltd.	16,119	$107.2K	0.00%
Susquehanna Portfolio Strategies, LLC	14,750	$98.1K	0.04%
Axq Capital, LP	14,600	$97.1K	0.04%
Fox Run Management, L.L.C.	13,780	$91.6K	0.01%
Virtus Investment Advisers, Inc.	13,323	$88.6K	0.02%
Creative Planning	12,598	$83.8K	0.00%
Quest Partners LLC	10,832	$72.0K	0.01%
Covestor Ltd	2,417	$16.0K	0.01%
Stone House Investment Management, LLC	500	$3.33K	0.00%
Montag A & Associates Inc	440	$2.93K	0.00%
Coldstream Capital Management Inc	55	$366	0.00%
Parkside Financial Bank & Trust	50	$332	0.00%
Larson Financial Group LLC	38	$253	0.00%
Parallel Advisors, LLC	24	$160	0.00%
Skopos Labs, Inc.	7	$47	0.00%

Sold out (27)

Institutions that held Stoke Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of STOK in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Norges Bank	314,800	$3.47M
Squarepoint Ops LLC	120,242	$1.33M
Exome Asset Management LLC	113,096	$1.25M
Group One Trading, L.P.	104,411	$1.15M
Panagora Asset Management Inc	104,272	$1.15M
Voloridge Investment Management, LLC	86,888	$958.4K
Two Sigma Investments, LP	53,950	$595.1K
Los Angeles Capital Management LLC	43,438	$479.1K
EntryPoint Capital, LLC	31,968	$352.6K
Prelude Capital Management, LLC	29,528	$325.7K
D. E. Shaw & Co., Inc.	28,043	$309.3K
Engineers Gate Manager LP	25,005	$275.8K
Tudor Investment Corp Et Al	18,258	$201.4K
Verition Fund Management LLC	15,160	$167.2K
PDT Partners, LLC	13,942	$153.8K
Voya Investment Management LLC	11,100	$122.4K
SG Americas Securities, LLC	10,768	$119.0K
Ameriprise Financial Inc	10,527	$116.1K
Teacher Retirement System of Texas	10,219	$113.0K
Ikarian Capital, LLC	6,798	$75.0K
Virtus ETF Advisers LLC	5,770	$63.6K
STRS Ohio	3,800	$41.9K
R Squared Ltd	440	$4.85K
Caitong International Asset Management Co., Ltd	59	$651
IFP Advisors, Inc	6	$66
EverSource Wealth Advisors, LLC	3	$33
Lazard Asset Management LLC	58	$0

Not filed for Q1 2025 yet (1)

Institutions that held Stoke Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding STOK in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	108,087	$1.19M